PHARMANETICS INC
10-Q, EX-27, 2000-08-10
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: PHARMANETICS INC, 10-Q, 2000-08-10
Next: LIFEF X INC, 424B3, 2000-08-10



<TABLE> <S> <C>

<ARTICLE>                     5

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                      DEC-31-2000
<PERIOD-START>                         JAN-01-2000
<PERIOD-END>                           JUN-30-2000
<CASH>                                       3,557
<SECURITIES>                                10,654
<RECEIVABLES>                                  968
<ALLOWANCES>                                   (30)
<INVENTORY>                                  1,370
<CURRENT-ASSETS>                            16,759
<PP&E>                                       7,595
<DEPRECIATION>                              (4,254)
<TOTAL-ASSETS>                              20,833
<CURRENT-LIABILITIES>                        1,969
<BONDS>                                          0
                            0
                                 10,036
<COMMON>                                         0
<OTHER-SE>                                   8,539
<TOTAL-LIABILITY-AND-EQUITY>                20,833
<SALES>                                      2,866
<TOTAL-REVENUES>                             3,490
<CGS>                                       (1,891)
<TOTAL-COSTS>                               (1,891)
<OTHER-EXPENSES>                            (3,785)
<LOSS-PROVISION>                                 0
<INTEREST-EXPENSE>                            (115)
<INCOME-PRETAX>                             (2,301)
<INCOME-TAX>                                     0
<INCOME-CONTINUING>                         (2,301)
<DISCONTINUED>                                   0
<EXTRAORDINARY>                                  0
<CHANGES>                                   (1,225)
<NET-INCOME>                                (3,526)
<EPS-BASIC>                                  (0.47)
<EPS-DILUTED>                                (0.47)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission